Literature DB >> 2794052

Plasma binding and transport of diazepam across the blood-brain barrier. No evidence for in vivo enhanced dissociation.

R K Dubey1, C B McAllister, M Inoue, G R Wilkinson.   

Abstract

The tissue uptake of extensively plasma-bound compounds is reportedly inconsistent with the conventional free-drug hypothesis limiting transport to unbound moiety in rapid intracapillary equilibrium with bound complex. Instead, protein-mediated/cell surface enhancement of dissociation has been postulated to occur in the microvasculature. This possibility was investigated by studying the passive transport of diazepam across the blood-brain barrier. Microdialysis probes placed within the vena cava and brain cortex were used to directly compare steady-state, interstitial unbound diazepam levels in both Wistar and genetically analbuminemic rats. The absence of albumin in the latter increased the unbound fraction of diazepam by almost fivefold; however, in both groups, the ratio of unbound concentrations in brain and blood at equilibrium was equal to unity. If enhanced dissociation occurred in the microvasculature, then the unbound brain level should have been greater than that in the systemic circulation. It is probable that earlier findings suggestive of protein-mediated transport reflect a nonequilibrium phenomenon. Comparison of the extent of diazepam's in vivo binding in blood by microdialysis to that estimated in vitro using conventional equilibrium dialysis with microcells showed good agreement, thus validating a widely accepted assumption of equivalency of these two values.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2794052      PMCID: PMC329772          DOI: 10.1172/JCI114279

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Receptor for albumin on the liver cell surface may mediate uptake of fatty acids and other albumin-bound substances.

Authors:  R Weisiger; J Gollan; R Ockner
Journal:  Science       Date:  1981-03-06       Impact factor: 47.728

2.  Studies of albumin binding to rat liver plasma membranes. Implications for the albumin receptor hypothesis.

Authors:  W Stremmel; B J Potter; P D Berk
Journal:  Biochim Biophys Acta       Date:  1983-03-15

3.  Hepatic uptake of albumin-bound substances: albumin receptor concept.

Authors:  R K Ockner; R A Weisiger; J L Gollan
Journal:  Am J Physiol       Date:  1983-07

4.  Tracer kinetic model of blood-brain barrier transport of plasma protein-bound ligands. Empiric testing of the free hormone hypothesis.

Authors:  W M Pardridge; E M Landaw
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

Review 5.  Transport of protein-bound hormones into tissues in vivo.

Authors:  W M Pardridge
Journal:  Endocr Rev       Date:  1981       Impact factor: 19.871

6.  Effect of albumin binding on the hepatic transport of rose bengal: surface-mediated dissociation of limited capacity.

Authors:  E L Forker; B A Luxon; M Snell; W O Shurmantine
Journal:  J Pharmacol Exp Ther       Date:  1982-11       Impact factor: 4.030

7.  Albumin-mediated transport of rose bengal by perfused rat liver. Kinetics of the reaction at the cell surface.

Authors:  E L Forker; B A Luxon
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

8.  In vitro correlates of benzodiazepine cerebrospinal fluid uptake, pharmacodynamic action and peripheral distribution.

Authors:  R M Arendt; D J Greenblatt; R H deJong; J D Bonin; D R Abernethy; B L Ehrenberg; H G Giles; E M Sellers; R I Shader
Journal:  J Pharmacol Exp Ther       Date:  1983-10       Impact factor: 4.030

9.  Blood-brain barrier transport of valproic acid.

Authors:  E M Cornford; C P Diep; W M Pardridge
Journal:  J Neurochem       Date:  1985-05       Impact factor: 5.372

10.  Albumin helps mediate removal of taurocholate by rat liver.

Authors:  E L Forker; B A Luxon
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

View more
  23 in total

1.  Pharmacokinetic estimations from microdialysis data.

Authors:  L Ståhle
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Distribution of diazepam, nordiazepam, and oxazepam between brain extraneuronal space, brain tissue, plasma, and cerebrospinal fluid in diazepam and nordiazepam dependent dogs.

Authors:  E P Wala; W R Martin; J W Sloan
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Drug equilibration across the blood-brain barrier--pharmacokinetic considerations based on the microdialysis method.

Authors:  M Hammarlund-Udenaes; L K Paalzow; E C de Lange
Journal:  Pharm Res       Date:  1997-02       Impact factor: 4.200

Review 4.  Application of microdialysis in pharmacokinetic studies.

Authors:  W F Elmquist; R J Sawchuk
Journal:  Pharm Res       Date:  1997-03       Impact factor: 4.200

5.  Heterogeneous Binding and Central Nervous System Distribution of the Multitargeted Kinase Inhibitor Ponatinib Restrict Orthotopic Efficacy in a Patient-Derived Xenograft Model of Glioblastoma.

Authors:  Janice K Laramy; Minjee Kim; Shiv K Gupta; Karen E Parrish; Shuangling Zhang; Katrina K Bakken; Brett L Carlson; Ann C Mladek; Daniel J Ma; Jann N Sarkaria; William F Elmquist
Journal:  J Pharmacol Exp Ther       Date:  2017-08-28       Impact factor: 4.030

6.  A novel tool to characterize paracellular transport: the APTS-dextran ladder.

Authors:  Winfried Neuhaus; Elisabeth Bogner; Michael Wirth; Joanna Trzeciak; Bodo Lachmann; Franz Gabor; Christian R Noe
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.200

7.  Microdialysis sampling to determine the pharmacokinetics of unbound SDZ ICM 567 in blood and brain in awake, freely-moving rats.

Authors:  M J Alonso; A Bruelisauer; P Misslin; M Lemaire
Journal:  Pharm Res       Date:  1995-02       Impact factor: 4.200

8.  Pharmacokinetic Assessment of Cooperative Efflux of the Multitargeted Kinase Inhibitor Ponatinib Across the Blood-Brain Barrier.

Authors:  Janice K Laramy; Minjee Kim; Karen E Parrish; Jann N Sarkaria; William F Elmquist
Journal:  J Pharmacol Exp Ther       Date:  2018-02-12       Impact factor: 4.030

9.  Microdialysis in pharmacokinetics.

Authors:  L Ståhle
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Jan-Mar       Impact factor: 2.441

10.  Structural sweet spot for A1 adenosine receptor activation by truncated (N)-methanocarba nucleosides: receptor docking and potent anticonvulsant activity.

Authors:  Dilip K Tosh; Silvia Paoletta; Francesca Deflorian; Khai Phan; Steven M Moss; Zhan-Guo Gao; Xiaohui Jiang; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2012-09-10       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.